title: Effect of second-stage 0.25% epidural bupivacaine on the outcome of labor.
abstract: OBJECTIVE
  To evaluate the effect of second-stage epidural bupivacaine on the outcome of labor.
  
  
  METHODS
  Two groups of 35 patients each were randomly allocated to receive continuous epidural bupivacaine throughout labor (group 1) or until an 8-cm dilatation of the cervix (group 2).
  
  
  RESULTS
  There was no significant difference between the 2 groups in the rates of instrument deliveries and in their Apgar scores.
  
  
  CONCLUSIONS
  The administration of continuous epidural bupivacaine (0.25%) throughout labor and delivery does not seem to affect the outcome of labor.
authors.affiliation: Department of Obstetrics and Gynecology, B, Serlin Maternity Hospital, Tel Aviv, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Luxman
authors.forename: I
authors.initials: I
authors.lastname: Wolman
authors.forename: D
authors.initials: D
authors.lastname: Niv
authors.forename: J R
authors.initials: JR
authors.lastname: Cohen
authors.forename: M
authors.initials: M
authors.lastname: Lottan
authors.forename: D
authors.initials: D
authors.lastname: Pauzner
authors.forename: A
authors.initials: A
authors.lastname: Groutz
authors.forename: M P
authors.initials: MP
authors.lastname: David
mesh_terms: D000328:Adult; D015360:Analgesia, Epidural; D016362:Analgesia, Obstetrical; D000704:Analysis of Variance; D001034:Apgar Score; D002045:Bupivacaine / Q000008:administration & dosage*; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007748:Labor Stage, Second; D011247:Pregnancy; D011446:Prospective Studies
chemical_list: D002045:Bupivacaine